A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.
Therarchon boosts series A to $40m
Bpifrance has joined a consortium of investors that already featured Inserm Transfer Initiative and that previously provided $35m in funding.
PvP Biologics studies $35m partnership
Takeda Pharmaceutical has signed a strategic agreement with PvP Biologics that gives the corporate an option to acquire the University of Washington spinout.
Imperial Innovations completes Touchstone rebrand
The change was proposed last October and approved at the commercialisation firm’s annual general meeting the following month.
Investors allocate $12m to Unicaf
University Ventures, CDC Group and Savannah Fund have injected $12m into Unicaf to help it establish learning centres across several African cities.
Heparegenix processes $9.4m series A
HTGF and Coparion have supported a series A round for Heparegenix, based on research at University Hospital Tübingen.
Marburg’s Mafex is open for business
Philipp University of Marburg has formally launched its institute to support innovation research and the creation of companies.
British Innovation Fund launched with $39m
Royal County of Berkshire Pension Fund has provided half the capital secured by the fund so far.
Indigo colours in $6m series A
Indigo Diabetes, a spinout of Ghent University and Imec, has raised the capital from a consortium of investors that included university venturing fund Qbic.
Deal net: 7 – 11 November 2016
The Global University Venturing deal net rounds up all the latest smaller deals and tracks emerging companies accessing university funds.